Hypericin sodium

金丝桃素

Report date: 2024/12/17 16:51:22
NME

Base Information

Drug NameHypericin sodium
Drug Alias NameHyBryteHypericinSynthetic hypericinVIMRxynSGX-301 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhotosensitizersCell death stimulantsHeat shock protein HSP90 inhibitors +[5] 
TargetsHeat shock protein HSP90Protein kinase CSinglet oxygen
Therapy Area/IndicationsPlaque psoriasisPsoriasisMycosis Fungoides +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesNew York UniversityWeizmann Institute Of Science
China Registration ClassN/A

Develop Information

Active CompaniesSoligenix Inc
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsPlaque psoriasisPsoriasisMycosis Fungoides +[4] 
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG